Dr. Yuling Li, CEO of Innoforce, presided over the “downstream separation and purification” session of The 2nd Asia Biopharma Continuous Manufacuturing and Process Innovation Conference 2020

On September 17, 2020, Dr. Yuling Li, CEO of Innoforce, presided over the “downstream separation and purification” session at the 2nd Asia Biopharma Continuous Manufacturing and Process Innovation Conference 2020”. She also presented a lecture on " Ensuring Viral Safety for Mab and Advanced Therapeutic Medical Products " to the participants.



Please scan the 2D code for more details

Top